PATENT CLAIM ANALYSIS

Application Number: 15764193
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "193000"]

Abstract:
Thalidomide analogs and methods of using the thalidomide analogs are disclosed. Some embodiments of the disclosed compounds exhibit anti-angiogenic and/or anti-inflammatory activity. Certain embodiments of the disclosed compounds are non-teratogenic.

Claim (Index 23):
The method according to  claim 12 , wherein the thalidomide analog or pharmaceutically acceptable salt thereof or the pharmaceutical composition is administered orally, parenterally, rectally, nasally, buccally, vaginally, topically, optically, by inhalation spray, or via an implanted reservoir.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 90.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13153355', '12767647', '10572485', '13498067', '13648625']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7828679647549188
- 35 USC 102 Novelty (BERT): 0.5129691680149155
- Combined Prediction Score: 0.7558780850809185
- Mean Citation Score: 257.70049
- Max Citation Score: 277.90332
- Similarity Product: 187.6892155337906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test